MedTrace Logo

A Comprehensive Optical Blood Pressure Assessment Tool to Identify Cases of Unscreened Hypertension Across an Active Population in the U.S.

NCT06721611 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2025-02-06

No results posted yet for this study

Summary

To screen for and identify subjects with potential undiagnosed hypertension using an optical blood pressure monitoring device across an active workforce population in the US (Nucor employees).

Conditions

Interventions

DEVICE

Optical Blood Pressure Monitoring Device (Aktiia G1)

Non-hypertensive Nucor employees that accept to wear an optical blood pressure monitoring device (Aktiia 24/7 device) to screen for and identify potential undiagnosed hypertension. 100 participants. Each participant will wear the device continuously for 28 days.

Sponsors & Collaborators

  • Nucor

    lead INDUSTRY

Eligibility

Min Age
25 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-16
Primary Completion
2025-07-16
Completion
2025-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06721611 on ClinicalTrials.gov